1. Home
  2. TRT vs RCEL Comparison

TRT vs RCEL Comparison

Compare TRT & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trio-Tech International

TRT

Trio-Tech International

HOLD

Current Price

$14.67

Market Cap

139.8M

Sector

Technology

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.93

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRT
RCEL
Founded
1958
N/A
Country
United States
United States
Employees
N/A
226
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.8M
126.8M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TRT
RCEL
Price
$14.67
$3.93
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
893.3K
202.2K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$32,462,000.00
N/A
Revenue This Year
N/A
$17.17
Revenue Next Year
N/A
$49.82
P/E Ratio
$630.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.42
$3.22
52 Week High
$21.38
$7.12

Technical Indicators

Market Signals
Indicator
TRT
RCEL
Relative Strength Index (RSI) 59.01 41.55
Support Level $5.82 $3.28
Resistance Level $14.78 $4.09
Average True Range (ATR) 1.51 0.24
MACD 0.09 -0.03
Stochastic Oscillator 82.00 19.18

Price Performance

Historical Comparison
TRT
RCEL

About TRT Trio-Tech International

Trio-Tech International is a provider of reliability test equipment and services to the semiconductor and other industries. Its customers are from automotive electronics, industrial electronics, computing and data storage, consumer electronics, and communication markets. The company operated its business in two segments: Semiconductor Back-end Solutions and Industrial Electronics. Geographically, the company operates in the United States (U.S), Singapore, Malaysia, Thailand and China.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: